Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
Healthcare · Drug Manufacturers—Specialty & Generic
AI confidence 70% · prior close shown (market closed)
Limited proprietary earnings coverage for KNSA yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 33d ago
Reported figures for Kiniksa Pharmaceuticals International, plc — research only, not investment advice.
Updated
What happened recently for Kiniksa Pharmaceuticals International, plc (KNSA) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
Prior close
$76.75
Market cap
$4.55B
Profitable
Yes
Revenue $214.27M
Net income
$22.59M
FY Jul 22, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Kiniksa Pharmaceuticals International, plc — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow Kiniksa Pharmaceuticals International, plc through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.